Correlation between the human fecal microbiota and depression

By Ali Naseribafrouei, K. Hestad, E. Avershina, M. Sekelja, A. Linløkken, R. C. Wilson, Knut Rudi. Neurogastroenterology and Motility, 2014

944 citations recorded by the source corpus.

Subfields: Gastroenterology, Infectious Diseases, Molecular Biology

View Paper: https://www.semanticscholar.org/paper/50d2a99798c8cc5cc60772d51329984303210029

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Gastroenterology

1. J. Cryan
2. Ted G. Dinan
3. G. Clarke
4. P. Kennedy
5. J. Foster

In Infectious Diseases

1. Paul D. Cotter
2. Ted G. Dinan
3. G. Clarke
4. J. Cryan

In Molecular Biology

1. J. Cryan
2. Ted G. Dinan
3. G. Clarke
4. P. Kennedy
5. R. Moloney
6. J. R. Kelly
7. Orla O'Sullivan
8. Paul D. Cotter

Citations in the corpus

• Impact of Omega-3 Fatty Acids on the Gut Microbiota (2017, background): “Both MDD and ASD are characterized by similar alterations in gut microbiota composition associated with a pro-inflammatory microbial profile [81,87,88].”
• Altered fecal microbiota composition in patients with major depressive disorder. (2015, background): “Consistent with previous animal and human studies (Bailey et al., 2011; Naseribafrouei et al., 2014), Bacteroides expression was significantly decreased in A-MDD vs. control patients.”
• The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems (2015, background): “In the meantime, emerging data support the role of microbiota in influencing anxiety and depressive-like behaviors [6,7] and, more recently, of dysbiosis in autism.”
• The Gut Microbiota and Alzheimer’s Disease (2017, neutral): “…disease (for review, see [15, 16]), type 2 diabetes mellitus (T2DM) [17, 18], obesity (for review, see [19, 20]), cardiovascular disease events [21, 22], autism [23, 24] (for review,see[24]),depression(forreview,see[25,26]), Parkinson’sdisease[27–29](forreview,see[28]), andmultiplesclerosis[30,31].”
• Kynurenine pathway metabolism and the microbiota‐gut‐brain axis (2017, background): “, 2016) although an independent study did not identify such differences (Naseribafrouei et al., 2014).”
• Gut microbiota depletion from early adolescence in mice: Implications for brain and behaviour. (2015, background): “Clinical studies reporting altered composition of the microbiota in disorders such as depression (Naseribafrouei et al., 2014; Dinan and Cryan, 2013), irritable bowel syndrome (Kennedy et al., 2014; Bonfrate et al., 2013; Jeffery et al., 2012), and autism (Finegold et al., 2010; Finegold, 2011;…”
• Breaking down the barriers: the gut microbiome, intestinal permeability and stress-related psychiatric disorders (2015, background): “However, there were no significant differences in species richness, α-diversity, or operational taxonomic units (Naseribafrouei et al., 2014).”